$2M grant awarded to study drug’s impact on Alzheimer’s patients

August 25, 2020

In the war on cancer and other diseases including COVID-19, old drugs approved for other conditions are being studied for new purposes. It’s a strategy that will now be tested in Alzheimer’s disease with a drug called rapamycin. A $2 million grant will enable a clinical trial in which 40 individuals with mild cognitive impairment […]

Mays Cancer Center awarded millions for research and recruitment

August 20, 2020

The Cancer Prevention and Research Institute of Texas awarded more than $10.3 million to the Mays Cancer Center.

Research shows new education program may increase hepatitis C screenings

August 10, 2020

A team of researchers from UT Health San Antonio and UT Southwestern have published a study in the Journal of Cancer Education showing that a new, shortened training program for health care providers may increase screenings for hepatitis C virus (HCV) across the region.

Third remdesivir study begins

August 7, 2020

UT Health San Antonio and its clinical partner University Health System are on the front lines working to find new treatments for COVID-19.

Fragile X syndrome discovery offers clue in autism

August 3, 2020

Structures called primary cilia – which act like TV antennas for cells to detect signals – are present in fewer numbers in mice born with Fragile X syndrome, according to researchers.

New insights about COVID-19 treatments for cancer patients

July 24, 2020

The new COVID-19 and Cancer Consortium study shows that patients who were treated with the antiviral drug remdesivir fared the best.

Coronavirus makes itself unrecognizable to cells

July 24, 2020

According to a new study, SARS coronavirus 2 (SARS-CoV-2) disguises itself so it can hide inside cells without being detected by the immune system in order to replicate.

Genes, cardiovascular health each factor into dementia risk

July 20, 2020

Researchers hope the study results will encourage people to exercise, reduce stress and eat a healthy diet.

Synapse-saving class of proteins discovered, opening intriguing possibilities in Alzheimer’s, schizophrenia

July 17, 2020

Researchers have discovered a new class of proteins that protect synapses from being destroyed. The discovery, published July 13 in the journal Nature Neuroscience, has implications for Alzheimer’s disease and schizophrenia.

Study hints at novel therapeutic target for Ewing sarcoma

July 16, 2020

New insights into Ewing sarcoma, an aggressive childhood cancer, were published July 15 in the prestigious journal Nature.